The noninvasive, quantitative, in vivo assessment of adenoviral-mediated gene delivery in skin wound biomaterials

Biomaterials

Volumn 30, Issue 35, 2009, Pages 6788-6793

  Peterson, Carrie Y ^a   Shaterian, Ashkaun ^a   Borboa, Alexandra K ^a   Gonzalez, Ana M ^b   Potenza, Bruce M ^a   Coimbra, Raul ^a   Eliceiri, Brian P ^a   Baird, Andrew ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Adenovirus; Bioluminescence imaging; Gene therapy; Growth factors; Scaffolds; Wound healing

Indexed keywords

ADENOVIRUS; BIOLUMINESCENCE IMAGING; GENE THERAPY; GROWTH FACTORS; WOUND HEALING;

BIOLOGICAL MATERIALS; BIOLUMINESCENCE; CELL CULTURE; DRUG DELIVERY; GENE EXPRESSION; GENE TRANSFER; GRAFTING (CHEMICAL); GRAFTS; LIGHT EMISSION; OPTIMIZATION; OPTOELECTRONIC DEVICES; PEPTIDES; PHOSPHORESCENCE; SCAFFOLDS;

BIOACTIVITY;

ADENOVIRUS VECTOR; BIOMATERIAL; FIBROBLAST GROWTH FACTOR 2; LUCIFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SKIN GRAFT; SKIN INJURY; VIRAL GENE DELIVERY SYSTEM; VIRUS PARTICLE; WOUND CLOSURE; WOUND HEALING;

ADENOVIRIDAE; ANIMALS; BIOCOMPATIBLE MATERIALS; FEASIBILITY STUDIES; FIBROBLAST GROWTH FACTOR 2; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; KINETICS; LUCIFERASES; MALE; MICE; MICE, INBRED C57BL; SKIN; TRANSDUCTION, GENETIC; WOUND HEALING;

ADENOVIRIDAE;

EID: 70349847557     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.07.069     Document Type: Article

References (50)

1. Bello Y.M., Falabella A.F., and Eaglstein W.H. Tissue-engineered skin. Current status in wound healing. Am J Clin Dermatol 2 5 (2001) 305-313
2. Auger F.A., Lacroix D., and Germain L. Skin substitutes and wound healing. Skin Pharmacol Physiol 22 2 (2009) 94-102
3. Doukas J., Chandler L.A., Gonzalez A.M., Gu D., Hoganson D.K., Ma C., et al. Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors. Hum Gene Ther 12 7 (2001 May 1) 783-798
4. Hirsch T., von Peter S., Dubin G., Mittler D., Jacobsen F., Lehnhardt M., et al. Adenoviral gene delivery to primary human cutaneous cells and burn wounds. Mol Med 12 9-10 (2006 Sep-Oct) 199-207
5. Stoff A., Rivera A.A., Banerjee N.S., Mathis J.M., Espinosa-de-los-Monteros A., Le L.P., et al. Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds. Wound Repair Regen 14 5 (2006 Sep-Oct) 608-617
6. Stoff A., Rivera A.A., Mathis J.M., Moore S.T., Banerjee N.S., Everts M., et al. Effect of adenoviral mediated overexpression of fibromodulin on human dermal fibroblasts and scar formation in full-thickness incisional wounds. J Mol Med 85 5 (2007 May) 481-496
7. Lee J.A., Conejero J.A., Mason J.M., Parrett B.M., Wear-Maggitti K.D., Grant R.T., et al. Lentiviral transfection with the PDGF-B gene improves diabetic wound healing. Plast Reconstr Surg 116 2 (2005 Aug) 532-538
8. Hansen S.L., Myers C.A., Charboneau A., Young D.M., and Boudreau N. HoxD3 accelerates wound healing in diabetic mice. Am J Pathol 163 6 (2003 Dec) 2421-2431
9. Asai J., Takenaka H., Kusano K.F., Ii M., Luedemann C., Curry C., et al. Topical sonic hedgehog gene therapy accelerates wound healing in diabetes by enhancing endothelial progenitor cell-mediated microvascular remodeling. Circulation 113 20 (2006 May 23) 2413-2424
10. Macri L., and Clark R.A. Tissue engineering for cutaneous wounds: selecting the proper time and space for growth factors, cells and the extracellular matrix. Skin Pharmacol Physiol 22 2 (2009) 83-93
11. Hansen S.L., Young D.M., and Boudreau N.J. HoxD3 expression and collagen synthesis in diabetic fibroblasts. Wound Repair Regen 11 6 (2003 Nov-Dec) 474-480
12. Bonadio J., Smiley E., Patil P., and Goldstein S. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 5 7 (1999 Jul) 753-759
13. Schillinger U., Wexel G., Hacker C., Kullmer M., Koch C., Gerg M., et al. A fibrin glue composition as carrier for nucleic acid vectors. Pharm Res 25 12 (2008 Dec) 2946-2962
14. Goldstein S.A., and Bonadio J. Potential role for direct gene transfer in the enhancement of fracture healing. Clin Orthop Relat Res 355 Suppl (1998 Oct) S154-S162
15. Bonadio J. Tissue engineering via local gene delivery. J Mol Med 78 6 (2000) 303-311
16. Shaterian A., Borboa A., Sawada R., Costantini T.W., Potenza B., Coimbra R., et al. Real time analysis of the kinetics of angiogenesis and vascular permeability in an animal model of wound healing. Burns 35 6 (2009 Sep) 811-817 [Epub 2009 May 6]
17. Liu P.Y., Wang X.T., Badiavas E., Rieger-Christ K., Tang J.B., and Summerhayes I. Enhancement of ischemic flap survival by prefabrication with transfer of exogenous PDGF gene. J Reconstr Microsurg 21 4 (2005 May) 273-279
18. Jiang S., Zavitz C.C., Wang J., Saraf A., Zielinski R., Ramsbottom J.D., et al. Non-adenine based purines accelerate wound healing. Purinergic Signal 2 4 (2006 Nov) 651-661
19. Braund R., Hook S., and Medlicott N.J. The role of topical growth factors in chronic wounds. Curr Drug Deliv 4 3 (2007 Jul) 195-204
20. Wu J.C., Sundaresan G., Iyer M., and Gambhir S.S. Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. Mol Ther 4 4 (2001 Oct) 297-306
21. Wang Y., Iyer M., Annala A.J., Chappell S., Mauro V., and Gambhir S.S. Noninvasive monitoring of target gene expression by imaging reporter gene expression in living animals using improved bicistronic vectors. J Nucl Med 46 4 (2005 Apr) 667-674
22. De A., Lewis X.Z., and Gambhir S.S. Noninvasive imaging of lentiviral-mediated reporter gene expression in living mice. Mol Ther 7 5 Pt 1 (2003 May) 681-691
23. Gu D.L., Nguyen T., Gonzalez A.M., Printz M.A., Pierce G.F., Sosnowski B.A., et al. Adenovirus encoding human platelet-derived growth factor-B delivered in collagen exhibits safety, biodistribution, and immunogenicity profiles favorable for clinical use. Mol Ther 9 5 (2004 May) 699-711
24. Yuan B., Zhao Z., Zhang Y.R., Wu C.T., Jin W.G., Zhao S., et al. Short-term safety and curative effect of recombinant adenovirus carrying hepatocyte growth factor gene on ischemic cardiac disease. In Vivo 22 5 (2008 Sep-Oct) 629-632
25. Keedy V., Wang W., Schiller J., Chada S., Slovis B., Coffee K., et al. Phase I study of adenovirus p53 administered by bronchoalveolar lavage in patients with bronchioloalveolar cell lung carcinoma: ECOG 6597. J Clin Oncol 26 25 (2008 Sep 1) 4166-4171
26. Doukas J., Blease K., Craig D., Ma C., Chandler L.A., Sosnowski B.A., et al. Delivery of FGF genes to wound repair cells enhances arteriogenesis and myogenesis in skeletal muscle. Mol Ther 5 5 Pt 1 (2002 May) 517-527
27. Jin Q., Anusaksathien O., Webb S.A., Printz M.A., and Giannobile W.V. Engineering of tooth-supporting structures by delivery of PDGF gene therapy vectors. Mol Ther 9 4 (2004 Apr) 519-526
28. Schreiber R.E., Blease K., Ambrosio A., Amburn E., Sosnowski B., and Sampath T.K. Bone induction by AdBMP-2/collagen implants. J Bone Joint Surg Am 87 5 (2005 May) 1059-1068
29. Berry M., Gonzalez A.M., Clarke W., Greenlees L., Barrett L., Tsang W., et al. Sustained effects of gene-activated matrices after CNS injury. Mol Cell Neurosci 17 4 (2001 Apr) 706-716
30. Gonzalez A.M., Berlanga O., Leadbeater W.E., Cooper-Charles L., Sims K., Logan A., et al. The deployment of adenovirus-containing gene activated matrices onto severed axons after CNS injury leads to transgene expression in target neuronal cell bodies. J Gene Med 11 8 (2009 Aug) 679-688
31. Davidson J.M. Growth factors: the promise and the problems. Int J Low Extrem Wounds 6 1 (2007 Mar) 8-10
32. Bonadio J. Tissue engineering via local gene delivery: update and future prospects for enhancing the technology. Adv Drug Deliv Rev 44 2-3 (2000 Nov 15) 185-194
33. Eming S.A., Krieg T., and Davidson J.M. Gene therapy and wound healing. Clin Dermatol 25 1 (2007 Jan-Feb) 79-92
34. Bouvet M., Wang J., Nardin S.R., Nassirpour R., Yang M., Baranov E., et al. Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Cancer Res 62 5 (2002 Mar 1) 1534-1540
35. Ke S., Wen X., Gurfinkel M., Charnsangavej C., Wallace S., Sevick-Muraca E.M., et al. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res 63 22 (2003 Nov 15) 7870-7875
36. Min J.J., Ahn Y., Moon S., Kim Y.S., Park J.E., Kim S.M., et al. In vivo bioluminescence imaging of cord blood derived mesenchymal stem cell transplantation into rat myocardium. Ann Nucl Med 20 3 (2006 Apr) 165-170
37. Engelsman A.F., van der Mei H.C., Francis K.P., Busscher H.J., Ploeg R.J., and van Dam G.M. Real time noninvasive monitoring of contaminating bacteria in a soft tissue implant infection model. J Biomed Mater Res B Appl Biomater 88 1 (2009 Jan) 123-129
38. Ryan P.L., Youngblood R.C., Harvill J., and Willard S.T. Photonic monitoring in real time of vascular endothelial growth factor receptor 2 gene expression under relaxin-induced conditions in a novel murine wound model. Ann N Y Acad Sci 1041 (2005 May) 398-414
39. Ho T.Y., Chen Y.S., and Hsiang C.Y. Noninvasive nuclear factor-kappaB bioluminescence imaging for the assessment of host-biomaterial interaction in transgenic mice. Biomaterials 28 30 (2007 Oct) 4370-4377
40. Hsiang C.Y., Chen Y.S., and Ho T.Y. Nuclear factor-kappaB bioluminescence imaging-guided transcriptomic analysis for the assessment of host-biomaterial interaction in vivo. Biomaterials 30 17 (2009 Jun) 3042-3049
41. Klerk C.P., Overmeer R.M., Niers T.M., Versteeg H.H., Richel D.J., Buckle T., et al. Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals. Biotechniques 43 1 Suppl (2007 Jul) 7-13 30
42. Jones I., Currie L., and Martin R. A guide to biological skin substitutes. Br J Plast Surg 55 3 (2002 Apr) 185-193
43. Nguyen D.Q., and Dickson W.A. A review of the use of a dermal skin substitute in burns care. J Wound Care 15 8 (2006 Sep) 373-376
44. Wieman T.J., Smiell J.M., and Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care 21 5 (1998 May) 822-827
45. Greenhalgh D.G., Sprugel K.H., Murray M.J., and Ross R. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 136 6 (1990 Jun) 1235-1246
46. Wang X.T., Liu P.Y., and Tang J.B. PDGF gene therapy enhances expression of VEGF and bFGF genes and activates the NF-kappaB gene in signal pathways in ischemic flaps. Plast Reconstr Surg 117 1 (2006 Jan) 129-137 [discussion: 138-129]
47. Lanciotti J., Song A., Doukas J., Sosnowski B., Pierce G., Gregory R., et al. Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates. Mol Ther 8 1 (2003 Jul) 99-107
48. Chandler L.A., Doukas J., Gonzalez A.M., Hoganson D.K., Gu D.L., Ma C., et al. FGF2-targeted adenovirus encoding platelet-derived growth factor-B enhances de novo tissue formation. Mol Ther 2 2 (2000 Aug) 153-160
49. Singer A.J., and Clark R.A. Cutaneous wound healing. N Engl J Med 341 10 (1999 Sep 2) 738-746
50. Huang S., Deng T., Wang Y., Deng Z., He L., Liu S., et al. Multifunctional implantable particles for skin tissue regeneration: preparation, characterization, in vitro and in vivo studies. Acta Biomater 4 4 (2008 Jul) 1057-1066